1. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project)
- Author
-
Bousquet, J. and Agache, I. and Aliberti, M.R. and Angles, R. and Annesi-Maesano, I. and Anto, J.M. and Arnavielhe, S. and Asayag, E. and Bacci, E. and Bedbrook, A. and Bachert, C. and Baroni, I. and Barreto, B.A. and Bedolla-Barajas, M. and Bergmann, K.C. and Bertorello, L. and Bewick, M. and Bieber, T. and Birov, S. and Bindslev-Jensen, C. and Blua, A. and Bochenska Marciniak, M. and Bogus-Buczynska, I. and Bosnic-Anticevich, S. and Bosse, I. and Bourret, R. and Bucca, C. and Buonaiuto, R. and Burguete Cabanas, M.T. and Caillaud, D. and Caimmi, D.P. and Caiazza, D. and Camargos, P. and Canfora, G. and Cardona, V. and Carriazo, A.M. and Cartier, C. and Castellano, G. and Chavannes, N.H. and Cecci, L. and Ciaravolo, M.M. and Cingi, C. and Ciceran, A. and Colas, L. and Colgan, E. and Coll, J. and Conforti, D. and Correia de Sousa, J. and Cortés-Grimaldo, R.M. and Corti, F. and Costa, E. and Courbis, A.L. and Cousein, E. and Cruz, A.A. and Custovic, A. and Cvetkovski, B. and Dario, C. and da Silva, J. and Dauvilliers, Y. and De Blay, F. and Dedeu, T. and De Feo, G. and De Martino, B. and Demoly, P. and De Vries, G. and Di Capua Ercolano, S. and Di Carluccio, N. and Doulapsi, M. and Dray, G. and Dubakiene, R. and Eller, E. and Emuzyte, R. and Espinoza-Contreras, J.G. and Estrada-Cardona, A. and Farrell, J. and Farsi, A. and Ferrero, J. and Fokkens, W.J. and Fonseca, J. and Fontaine, J.F. and Forti, S. and Gálvez-Romero, J.L. and García-Cobas, C.I. and Garcia Cruz, M.H. and Gemicioğlu, B. and Gerth van Wijk, R. and Guidacci, M. and Gómez-Vera, J. and Guldemond, N.A. and Gutter, Z. and Haahtela, T. and Hajjam, J. and Hellings, P.W. and Hernández-Velázquez, L. and Illario, M. and Ivancevich, J.C. and Jares, E. and Joos, G. and Just, J. and Kalayci, O. and Kalyoncu, A.F. and Karjalainen, J. and Keil, T. and Khaltaev, N. and Klimek, L. and Kritikos, V. and Kull, I. and Kuna, P. and Kvedariene, V. and Kolek, V. and Krzych-Fałta, E. and Kupczyk, M. and Lacwik, P. and La Grutta, S. and Larenas-Linnemann, D. and Laune, D. and Lauri, D. and Lavrut, J. and Lessa, M. and Levato, G. and Lewis, L. and Lieten, I. and Lipiec, A. and Louis, R. and Luna-Pech, J.A. and Magnan, A. and Malva, J. and Maspero, J.F. and Matta-Campos, J.J. and Mayora, O. and Medina-Ávalos, M.A. and Melén, E. and Menditto, E. and Millot-Keurinck, J. and Moda, G. and Morais-Almeida, M. and Mösges, R. and Mota-Pinto, A. and Mullol, J. and Muraro, A. and Murray, R. and Noguès, M. and Nalin, M. and Napoli, L. and Neffen, H. and O'Hehir, R.E. and Onorato, G.L. and Palkonen, S. and Papadopoulos, N.G. and Passalacqua, G. and Pépin, J.L. and Pereira, A.M. and Persico, M. and Pfaar, O. and Pozzi, A.C. and Prokopakis, E. and Pugin, B. and Raciborski, F. and Rimmer, J. and Rizzo, J.A. and Robalo-Cordeiro, C. and Rodríguez-González, M. and Rolla, G. and Roller-Wirnsberger, R.E. and Romano, A. and Romano, M. and Romano, M.R. and Salimäki, J. and Samolinski, B. and Serpa, F.S. and Shamai, S. and Sierra, M. and Sova, M. and Sorlini, M. and Stellato, C. and Stelmach, R. and Strandberg, T. and Stroetmann, V. and Stukas, R. and Szylling, A. and Tan, R. and Tibaldi, V. and Todo-Bom, A. and Toppila-Salmi, S. and Tomazic, P. and Trama, U. and Triggiani, M. and Valero, A. and Valovirta, E. and Valiulis, A. and van Eerd, M. and Vasankari, T. and Vatrella, A. and Ventura, M.T. and Verissimo, M.T. and Viart, F. and Williams, S. and Wagenmann, M. and Wanscher, C. and Westman, M. and Wickman, M. and Young, I. and Yorgancioglu, A. and Zernotti, E. and Zuberbier, T. and Zurkuhlen, A. and De Oliviera, B. and Senn, A., MACVIA-France, Contre les MAladies Chroniques pour un VIeillissement Actif en France European Innovation Partnership on Active and Healthy Ageing Reference Site, Montpellier, France, VIMA, INSERM U 1168, VIMA: Ageing and Chronic Diseases, Epidemiological and Public Health Approaches, Villejuif, France, Université Versailles St-Quentin-en-Yvelines, UMR-S 1168, Montigny le Bretonneux, France, Faculty of Medicine, Transylvania University, Brasov, Romania, Municipality of Salerno, Salerno, Italy, Innovación y nuevas tecnologías, Salud Sector sanitario de Barbastro, Barbastro, Spain, EPAR U707 INSERM, Paris, France, EPAR UMR-S UPMC, Paris VI, Paris, France, ISGLoBAL, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain, IMIM (Hospital del Mar Research Institute), Universitat Pompeu Fabra (UPF), Barcelona, Spain, CIBER Epidemiología y Salud Pública (CIBERESP), Universitat Pompeu Fabra (UPF), Barcelona, Spain, Kyomed, Montpellier, France, Argentine Society of Allergy and Immunopathology, Buenos Aires, Argentina, Regione Liguria, Genoa, Italy, Upper Airways Research Laboratory, ENT Department, Ghent University Hospital, Ghent, Belgium, Telbios SRL, Milan, Italy, Alergologo, Belem, Brazil, Hospital Civil de Guadalajara Dr. Juan I. Menchaca, Guadalarara, Mexico, Comprehensive Allergy-Centre-Charité, Department of Dermatology and Allergy, Charité-Universitätsmedizin Berlin, Berlin, Germany, Global Allergy and Asthma European Network (GA2LEN), Berlin, Germany, iQ4U Consultants Ltd, London, United Kingdom, Department of Dermatology and Allergy, Rheinische Friedrich-Wilhelms-University, Bonn, Germany, Empirica Communication and Technology Research, Bonn, Germany, Department of Dermatology and Allergy Centre, Odense University Hospital, Odense, Denmark, Argentine Association of Respiratory Medicine, Buenos Aires, Argentina, Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland, Woolcock Institute of Medical Research, University of Sydney and Sydney Local Health District, Glebe, NSW, Australia, Allergist, La Rochelle, France, Centre Hospitalier Valenciennes, Valenciennes, France, Chief of the University Pneumology Unit- AOU Molinette, Hospital City of Health and Science of Torino, Torino, Italy, Pharmacist of COFASER - Consorzio Farmacie Servizi-Salerno, Salerno, Italy, Centro Médico Zambrano Hellion, Monterrey, Mexico, Gesundheitsregion KölnBonn - HRCB Projekt GmbH, Kohln, Germany, Service de pneumologie, CHU et université d'Auvergne, Clermont-Ferrand, France, Department of Respiratory Diseases, Montpellier University Hospital, Montpellier, France, Department of Pediatrics, Medical School, Federal University of Minas Gerais, Belo Horizonte, Brazil, Mayor of Sarno and President of Salerno Province, Anesthesiology Service, Sarno 'Martiri del Villa Malta' Hospital, Sarno, Italy, S. Allergologia, S. Medicina Interna, Hospital Vall d'Hebron, Barcelona, Spain, Regional Ministry of Health of Andalusia, Seville, Spain, ASA - Advanced Solutions Accelerator, Clapiers, France, Celentano Pharmacy, Massa Lubrense, Italy, Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands, S.O.S Allergology and Clinical Immunology, USL Toscana Centro, Prato, Italy, Specialist Social Worker, Sorrento, Italy, ENT Department, Medical Faculty, Eskisehir Osmangazi University, Eskisehir, Turkey, Argentine Federation of Otorhinolaryngology Societies, Buenos Aires, Argentina, Service de Pneumologie, UMR INSERM, UMR1087and CNR 6291, l'institut du thorax, University of Nantes, Nantes, France, Department of Health, Social Services and Public Safety, Belfast, United Kingdom, Fondazione Bruno Kessler (FBK), Trento, Italy, Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal, Alergologa, Guadalarara, Mexico, FIMMG (Federazione Italiana Medici di Medicina Generale), Milan, Italy, UCIBIO, REQYULTE, Faculty of Pharmacy and Competence Center on Active and Healthy Ageing of University of Porto (AgeUPNetWork), Porto, Portugal, Ecole des Mines, Alès, France, Vice Président de la CME - Centre Hospitalier, Valenciennes, France, ProAR – Nucleo de Excelencia em Asma, Federal University of Bahia, Bahia, Brazil, GARD/WHO Executive Committee and Federal University of Bahia, Bahia, Brazil, Department of Pediatric, Imperial College London, London, United Kingdom, Azienda Provinciale per i Servizi Sanitari di Trento (APSS-Trento), Trento, Italy, Allergy Service, University Hospital of Federal University of Santa Catarina (HU-UFSC), Florianópolis, Brazil, Sleep Unit, Department of Neurology, Hôpital Gui-de-Chauliac Montpellier, Inserm U1061, Montpellier, France, Allergy Division, Chest Disease Department, University Hospital of Strasbourg, Strasbourg, France, AQuAS, Barcelona, Spain & EUREGHA, European Regional and Local Health Association, Brussels, Belgium, Department of Medicine, Surgery and Dentistry 'Scuola Medica Salernitana', University of Salerno, Salerno, Italy, Social Workers Coordinator, Sorrento, Italy, Peercode DV, Gerdermalsen, Netherlands, Farmacie Dei Golfi Group, Massa Lubrense, Italy, Department of Otolaryngology, University of Crete School of Medicine, Heraklion, Greece, Medical Faculty, Vilnius University, Vilnius, Lithuania, Clinic of Children's Diseases, Faculty of Medicine, Vilnius University, Vilnius, Lithuania, University of Aguascalientes, Chihuaha, Mexico, Alergologo, Playa del Carmen, Mexico, Andalusian Agency for Healthcare Quality, Seville, Spain, Department of Otorhinolaryngology, Academic Medical Centre, Amsterdam, Netherlands, Center for Health Technology and Services Research- CINTESIS, Faculdade de Medicina, Universidade do Porto, Porto, Portugal, Allergy Unit, CUF Porto Instituto & Hospital, Porto, Portugal, Allergist, Reims, France, Regional Hospital of ISSSTE, Puebla, Mexico, Alergologo, Guadalarara, Mexico, Allergy Clinic, National Institute of Respiratory Diseases, Mexico City, Mexico, Department of Pulmonary Diseases, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey, Department of Internal Medicine, Section of Allergology, Erasmus MC, Rotterdam, Netherlands, Member of the Brazilian Society of Pediatrics and Society of Immunization, Representative of GINA (Global Initiative Against Asthma), Brasilia, Brazil, Allergy Clinic, Hospital Regional del ISSSTE ‘Lic. López Mateos’, Mexico City, Mexico, Institute of Health Policy and Management iBMG, Erasmus University, Rotterdam, Netherlands, University Hospital Olomouc – National eHealth Centre, Olomouk, Czech Republic, Skin and Allergy Hospital, Helsinki University Hospital, Helsinki, Finland, Centich: centre d'expertise national des technologies de l'information et de la communication pour l'autonomie, Gérontopôle autonomie longévité des Pays de la Loire, Conseil régional des Pays de la Loire, Centre d'expertise Partenariat Européen d'Innovation pour un vieillissement actif et en bonne santé, Nantes, France, Laboratory of Clinical Immunology, Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium, Alergologo, Ensenada, Mexico, Division for Health Innovation, Campania Region and Federico II University Hospital Naples (R&D and DISMET), Naples, Italy, Servicio de Alergia e Immunologia, Clinica Santa Isabel, Buenos Aires, Argentina, Libra Foundation, Buenos Aires, Argentina, Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium, Allergology Department, Centre de l'Asthme et des Allergies, Hôpital d'Enfants Armand-Trousseau (APHP, Paris), Paris, France, Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Equipe EPAR, Paris, France, Pediatric Allergy and Asthma Unit, Hacettepe University School of Medicine, Ankara, Turkey, Immunology and Allergy Division, Department of Chest Diseases, School of Medicine, Hacettepe University, Ankara, Turkey, Allergy Centre, Tampere University Hospital, Tampere, Finland, Institute of Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, Berlin, and Institute for Clinical Epidemiology and Biometry, University of Wuerzburg, Wuerzburg, Germany, GARD, Geneva, Switzerland, Center for Rhinology and Allergology, Wiesbaden, Germany, Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden, Clinic of Infectious, Chest Diseases, Dermatology and Allergology, Vilnius University, Vilnius, Lithuania, Department of Respiratory Medicine, Faculty of Medicine and Dentistry, University Hospital, Olomouc, Czech Republic, Department of Prevention of Environmental Hazards and Allergology, Medical University of Warsaw, Warsaw, Poland, Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council (CNR), Palermo, Italy, Clínica de Alergia, Asma y Pediatría, Hospital Médica Sur, México City, Mexico, Presidente CMMC, Milano, Italy, Head of the Allergy Department of Pedro de Elizalde Children's Hospital, Buenos Aires, Argentina, Faculdade de Medicina da Universidade Federal da Bahia, Salvador de Bahia, Brazil, Sifmed, Milano, Italy, Promotor B3 Action GRoup EIP on AHA and Senior Fellow, International Foundation for Integreted Care, Aberystwyth, United Kingdom, Tech Life Valley, Diepenbeek, Belgium, Department of Pulmonary Medicine, CHU Sart-Tilman, Liege, Belgium, University of Guadalajara, Guadalara, Mexico, Faculty of Medicine, Institute of Biomedical Imaging and Life Sciences (IBILI), University of Coimbra, Coimbra, Portugal, Ageing@Coimbra EIP-AHA Reference Site, Coimbra, Portugal, Argentine Association of Allergy and Clinical Immunology, Buenos Aires, Argentina, Hospital Regional Siglo XXI, Mexico City, Mexico, Alergologo, Veracruz, Mexico, Sachs’ Children and Youth Hospital, Södersjukhuset, Stockholm and Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden, CIRFF, Federico II University, Naples, Italy, Caisse d'assurance retraite et de la santé au travail du Languedoc-Roussillon (CARSAT-LR), Montpellier, France, Regione Piemonte, Torino, Italy, Allergy and Clinical Immunology Department, Hospital CUF-Descobertas, Lisboa, Portugal, Institute of Medical Statistics, Informatics and Epidemiology, Medical Faculty, University of Cologne, Cologne, Germany, Laboratory of General Pathology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal, Institute of Biomedical Imaging and Life Sciences (IBILI), Faculty of Medicine, University of Coimbra, Coimbra, Portugal, Clinical & Experimental Respiratory Immunoallergy, ENT Department, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Barcelona, Spain, Department of Women and Child Health, Food Allergy Referral Centre Veneto Region, Padua General University Hospital, Padua, Italy, MedScript Ltd, Dundalk, Co. Louth, Ireland, Consortium of Pharmacies and Services COSAFER, Salerno, Italy, Head of Respiratory Medicine, Alassia Children's Hospital, Center for Allergy and Immunology, Santa Fe, Argentina, Department of Allergy, Immunology and Respiratory Medicine, Alfred Hospital and Central Clinical School, Monash University, Melbourne, VIC, Australia, EFA European Federation of Allergy and Airways Diseases Patients’ Associations, Brussels, Belgium, Center for Pediatrics and Child Health, Institute of Human Development, Royal Manchester Children's Hospital, University of Manchester, Manchester, United Kingdom, Allergy Department, 2nd Pediatric Clinic, Athens General Children's Hospital 'P&A Kyriakou', University of Athens, Athens, Greece, Allergy and Respiratory Diseases, IRCCS San Martino Hospital-IST-University of Genoa, Genoa, Italy, Department of Pneumology, CHU Grenoble, Grenoble, France, Allergy Unit, CUF-Porto Hospital and Institute, Center for Research in Health Technologies and Information Systems, CINTESIS, Universidade do Porto, Porto, Portugal, Sociologist, Municipality, Sorrento, Italy, Vice-Presidente of IML, Milano, Italy, Alergista, Recife, Brazil, Centre of Pneumology, Coimbra University Hospital, Coimbra, Portugal, Alergologo, Mexico City, Mexico, Medical University of Graz, Graz, Austria, Allergy Unit, Presidio Columbus, Rome, Catholic University of Sacred Heart, Rome, Italy, IRCCS Oasi Maria S.S., Troina, Italy, Association of Finnish Pharmacists, Helsinki, Finland, Allergist, Vitoria, Brazil, Departement of Internal Medicine, University Hospital, Olomouc, Czech Republic, IML (Lombardy Medical Initiative), Bergamo, Italy, Pulmonary Division, Heart Institute (InCor), Hospital da Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, Sao Paulo, Brazil, Center for Life Course Health Research, Helsinki University Hospital, Helsinki University, University of Oulu, Oulu, Finland, Public Health Institute of Vilnius University, Vilnius, Lithuania, Imunoalergologia, Centro Hospitalar Universitário de Coimbra and Faculty of Medicine, University of Coimbra, Coimbra, Portugal, Department of ENT, Medical University of Graz, Graz, Austria, Division on Pharmacy and Devices Policy, Campania Region, Naples, Italy, Pneumology and Allergy Department, Hospital Clínic, Clinical & Experimental Respiratory Immunoallergy, IDIBAPS, CIBERES, University of Barcelona, Barcelona, Spain, Department of Lung Diseases and Clinical Allergology, University of Turku, Turku, Finland, Allergy Clinic, Terveystalo, Turku, Finland, Vilnius University Clinic of Children's Diseases and Public Health Institute, Vilnius, Lithuania, European Academy of Paediatrics (EAP/UEMS-SP), Brussels, Belgium, FILHA, Finnish Lung Association, Helsinki, Finland, Unit of Geriatric Immunoallergology, University of Bari Medical School, Bari, Italy, International Primary Care Respiratory Group IPCRG, Aberdeen, United Kingdom, Department of Otorhinolaryngology, HNO-Klinik, Universitätsklinikum Düsseldorf, Düsseldorf, Germany, EIP on AHA Coordinator, Region of Southern Denmark, Odense, Denmark, Department of Medicine Solna, Immunology and Allergy Unit, Karolinska Institutet and Department of ENT Diseases, Karolinska University Hospital, Stockholm, Sweden, Queen's University, Belfast, United Kingdom, Celal Bayar University Department of Pulmonology, GARD Executive Committee, Manisa, Turkey, Universidad Católica de Córdoba, Córdoba, Argentina, and EC-CNECT-H2, European Commission, Brussels, Belgium
- Subjects
humanities - Abstract
The overarching goals of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) are to enable European citizens to lead healthy, active and independent lives whilst ageing. The EIP on AHA includes 74 Reference Sites. The aim of this study was to transfer innovation from an app developed by the MACVIA-France EIP on AHA reference site (Allergy Diary) to other reference sites. The phenotypic characteristics of rhinitis and asthma multimorbidity in adults and the elderly will be compared using validated information and communication technology (ICT) tools (i.e. the Allergy Diary and CARAT: Control of Allergic Rhinitis and Asthma Test) in 22 Reference Sites or regions across Europe. This will improve the understanding, assessment of burden, diagnosis and management of rhinitis in the elderly by comparison with an adult population. Specific objectives will be: (i) to assess the percentage of adults and elderly who are able to use the Allergy Diary, (ii) to study the phenotypic characteristics and treatment over a 1-year period of rhinitis and asthma multimorbidity at baseline (cross-sectional study) and (iii) to follow-up using visual analogue scale (VAS). This part of the study may provide some insight into the differences between the elderly and adults in terms of response to treatment and practice. Finally (iv) work productivity will be examined in adults. © 2017 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.
- Published
- 2018